- RxSight, Inc. To Participate in the Truist Securities Medtech Conference
- RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
- RxSight, Inc. Announces Pricing of Public Offering of Common Stock
- RxSight, Inc. Announces Proposed Public Offering of Common Stock
- RxSight, Inc. Reports First Quarter 2024 Financial Results
- RxSight, Inc. to Present at the Bank of America Healthcare Conference
- RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
- RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
- RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
More ▼
Key statistics
On Monday, Rxsight Inc (RXST:NMQ) closed at 56.95, -14.41% below its 52-week high of 66.54, set on May 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 57.32 |
---|---|
High | 57.48 |
Low | 56.55 |
Bid | 56.59 |
Offer | 57.50 |
Previous close | 56.95 |
Average volume | 447.87k |
---|---|
Shares outstanding | 38.95m |
Free float | 36.92m |
P/E (TTM) | -- |
Market cap | 2.22bn USD |
EPS (TTM) | -1.25 USD |
Data delayed at least 15 minutes, as of Jul 08 2024 21:00 BST.
More ▼